Reversal of lung fibrosis in mouse model suggests a novel therapeutic target for pulmonary fibrosis. ScienceDaily . Retrieved May 25, 2025 from www.sciencedaily.com / releases / 2021 / 08 ...

Using a mouse model for lung fibrosis elicited by the anti-cancer drug bleomycin, the research team found metformin treatment, starting three weeks after lung injury and continuing for five weeks ...

Pulmonary fibrosis caused by this drug, as well as Idiopathic Pulmonary Fibrosis (IPF) from unknown causes, affect nearly five million people worldwide. No therapy is known to improve the health ...

Regardless of the exact prevalence of each condition, idiopathic pulmonary fibrosis, chronic hypersensitivity ... MMP matrix metalloproteinase, PDGF platelet-derived growth factor, PDGFR platelet ...

A RIKEN-developed mouse model of an enigmatic lung disease ... The research is published in Nature Communications. Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease in which ...

Reporting in the Journal of Experimental Medicine, Paul Noble, M.D., and colleagues say their findings were supported by subsequent studies in human patients with idiopathic pulmonary fibrosis (IPF).

Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly ... they analyzed both human and mouse IPF lung tissue and found ...

"Using a combination of molecular, biochemistry and microscopy techniques in mouse models, 3D lung organoids and tissue samples of pulmonary fibrosis, we examined the molecular mechanisms that ...

and they were also protected from asbestos-induced lung fibrosis. These conditional deletion results set the stage for the experiments showing that the Bcl-2 inhibitor ABT-199 was able to reverse ...

Pulmonary fibrosis caused by this drug, as well as Idiopathic Pulmonary Fibrosis (IPF) from unknown causes, affect nearly five million people worldwide. No therapy is known to improve the health ...